Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.
Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, Meterissian S, Arnaout A, Brackstone M, McCready DR, Karp SE, Trop I, Lisbona A, Wright FC, Younan RJ, Provencher L, Patocskai E, Omeroglu A, Robidoux A. Boileau JF, et al. Among authors: patocskai e. J Clin Oncol. 2015 Jan 20;33(3):258-64. doi: 10.1200/JCO.2014.55.7827. Epub 2014 Dec 1. J Clin Oncol. 2015. PMID: 25452445 Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 36428026
The contribution of founder mutations to early-onset breast cancer in French-Canadian women.
Ghadirian P, Robidoux A, Zhang P, Royer R, Akbari M, Zhang S, Fafard E, Costa M, Martin G, Potvin C, Patocskai E, Larouche N, Younan R, Nassif E, Giroux S, Narod SA, Rousseau F, Foulkes WD. Ghadirian P, et al. Among authors: patocskai e. Clin Genet. 2009 Nov;76(5):421-6. doi: 10.1111/j.1399-0004.2009.01277.x. Clin Genet. 2009. PMID: 19863560
Validation study of the s classification for melanoma patients with positive sentinel nodes: the Montreal experience.
Younan R, Bougrine A, Watters K, Mahboubi A, Bouchereau-Eyegue M, Loutfi A, Tremblay F, Bouffard D, Belisle A, Leblanc G, Nassif E, Martin G, Patocskai E, Alenezi M, Meterissian S. Younan R, et al. Among authors: patocskai e. Ann Surg Oncol. 2010 May;17(5):1414-21. doi: 10.1245/s10434-009-0876-8. Epub 2010 Feb 4. Ann Surg Oncol. 2010. PMID: 20131017
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5.
Smith JW 2nd, Buyse ME, Rastogi P, Geyer CE Jr, Jacobs SA, Patocskai EJ, Robidoux A, Conlin AK, Ansari B, Keogh GP, Stella PJ, Gross HM, Lord RS, Polikoff JA, Mauquoi C, Mamounas EP, Swain SM, Wolmark N. Smith JW 2nd, et al. Among authors: patocskai ej. Clin Breast Cancer. 2017 Feb;17(1):48-54.e3. doi: 10.1016/j.clbc.2016.07.008. Epub 2016 Jul 28. Clin Breast Cancer. 2017. PMID: 27693116 Clinical Trial.
Breast magnetic resonance imaging: are those who need it getting it?
Tan S, David J, Lalonde L, El Khoury M, Labelle M, Younan R, Patocskai E, Richard J, Trop I. Tan S, et al. Among authors: patocskai e. Curr Oncol. 2017 Jun;24(3):e205-e213. doi: 10.3747/co.24.3441. Epub 2017 Jun 27. Curr Oncol. 2017. PMID: 28680288 Free PMC article.
39 results